methotrexate has been researched along with Leishmaniasis, Cutaneous in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, VS; Castanheira, GV; Celeste, BJ; Emori, CT; Maia da Silva, CA; Maia de Souza, R; Moyses Franco, LA; Ruedas Martins, RC; Tuon, FF | 1 |
| Chiarri Toumit, C; Hernandez Bel, L; Hernández Garfella, ML; Valenzuela Oñate, C | 1 |
| Azzopardi, CM; Micallef, C | 1 |
| Akrout, R; Baklouti, S; Fourati, H; Hachicha, I; Hdiji, N; Sellami, M | 1 |
| Aguado-Lobo, M; Borbujo, J; Espinosa-Lara, P; García-Donoso, C; Martínez-Sánchez, D; Moreno-Torres, A; Romero-Maté, A; Tardío, JC | 1 |
| Kennedy, C; McBride, S; Saha, M; Shipley, D; Vega-Lopez, F | 1 |
| Beverley, SM; Hickerson, SM; Scott, DA; Vickers, TJ | 1 |
7 other study(ies) available for methotrexate and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Case Report: Cutaneous Leishmaniasis in a Rheumatoid Arthritis Patient Receiving Methotrexate.
Topics: Arthritis, Rheumatoid; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Methotrexate | 2022 |
Anti-tumour necrosis factor-induced cutaneous leishmaniasis in patient with psoriatic arthritis and uveitis.
Topics: Adalimumab; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Disease Susceptibility; Drug Therapy, Combination; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Male; Methotrexate; Prednisone; Tumor Necrosis Factor-alpha; Uveitis, Anterior | 2018 |
Atypical cutaneous leishmaniasis in the immunosuppressed.
Topics: Adalimumab; Amoxicillin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antimony Sodium Gluconate; Antiprotozoal Agents; Arthritis; Ciprofloxacin; Coinfection; DNA, Protozoan; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmania donovani; Leishmaniasis, Cutaneous; Methotrexate; Middle Aged | 2014 |
[Cutaneous leishmaniasis in rheumatoid arthritis].
Topics: Adult; Antiprotozoal Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds; Prednisone | 2009 |
Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab.
Topics: Adalimumab; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds | 2012 |
Atypical cutaneous leishmaniasis in two patients receiving low-dose methotrexate.
Topics: Adult; Aged; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Male; Methotrexate; Opportunistic Infections | 2006 |
The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major.
Topics: Animals; Genome, Protozoan; Glycine Dehydrogenase (Decarboxylating); Green Fluorescent Proteins; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Methotrexate; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Mitochondria; Models, Genetic; Mutation; Phenotype; Protozoan Proteins; Recombinant Fusion Proteins; Trypanosoma brucei brucei; Virulence | 2008 |